Prof. Iwona Ługowska Appointed President of the Organisation of European Cancer Institutes
Prof. Iwona Ługowska, a clinical oncologist at the Maria Sklodowska-Curie National Research Institute of Oncology (MSCNRIO), has been appointed President of the Organisation of European Cancer Institutes (OECI). The appointment was finalized during the OECI General Assembly in Warsaw, held this June. She succeeds the previous leadership to oversee strategic initiatives in European oncology research, accreditation, and patient care standards.
How does this appointment influence European oncology?
As President of the OECI, Prof. Ługowska will guide the organization’s strategic direction regarding clinical research, innovation, and the integration of oncology networks. According to the MSCNRIO, her role centers on harmonizing treatment quality and research protocols across European cancer centers. This leadership position ensures that Polish oncological expertise directly informs the development of healthcare systems and patient-centric solutions at a continental level.
Prof. Ługowska is the second representative from the National Institute of Oncology to lead the OECI. The first was Prof. Andrzej Kułakowski, a foundational figure in Polish oncological surgery who served in the 1990s.
What is the significance of the Center of Excellence for Precision Medicine?
Prof. Ługowska currently serves as the Head of the NIO Center of Excellence for Precision Medicine. Her expertise in this field is expected to shape OECI’s approach to personalized treatment protocols. By leveraging data-driven research, the OECI aims to improve survival rates and reduce the burden on healthcare systems. This focus aligns with broader European efforts to standardize genomic testing and targeted therapies across member institutes.
How does this leadership transition compare to the past?
The transition marks a return to Polish leadership within the OECI after several decades. While Prof. Kułakowski established the institute’s reputation in the 1990s through surgical innovation, Prof. Ługowska’s tenure is defined by the shift toward precision medicine and international network integration. This contrast highlights how the focus of European oncology has evolved from surgical advancement to the complex, multidisciplinary landscape of molecular diagnostics and collaborative research networks.
Pro Tips for Oncology Centers
- Standardize Accreditation: Follow OECI guidelines to align clinical research with European benchmarks.
- Collaborative Networks: Join international working groups to share data on precision oncology outcomes.
- Patient-Centric Care: Prioritize the integration of patient-reported outcomes into clinical trial design.
Frequently Asked Questions
Who is Prof. Iwona Ługowska?
Prof. Iwona Ługowska is a clinical oncologist and the Head of the NIO Center of Excellence for Precision Medicine at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw.
What does the OECI do?
The Organisation of European Cancer Institutes (OECI) is a non-governmental organization that works to improve cancer care and research through accreditation, collaboration, and the development of standardized oncology networks across Europe.
How long has the OECI been active?
The organization has been active for several decades, with notable Polish leadership dating back to the 1990s under Prof. Andrzej Kułakowski.
Stay informed on the latest developments in oncology research by subscribing to our newsletter. Explore our archives for more updates from the Maria Sklodowska-Curie National Research Institute of Oncology.
Keep reading